A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 5 December 2023) has been published and includes articles on:

Aripiprazole (Abilify and generic brands): risk of pathological gambling
Vitamin B12 (hydroxocobalamin, cyanocobalamin): advise patients with known cobalt allergy to be vigilant for sensitivity reactions
Letters and medicine recalls sent to healthcare professionals in November 2023.

To see the latest MHRA Drug Safety Updates in full, visit the GOV.uk website.

The post MHRA Drug Safety Update: December 2023 appeared first on Community Pharmacy England.